Pharmafile Logo
Pharmafocus logo
Advanced Search

Sales and Marketing

Showing 15 posts of 11527 posts found.

Roche impresses at ASCO with vemurafenib

June 6, 2011 Research and Development, Sales and Marketing ASCO, Roche, skin cancer, vemurafenib

Roche’s vemurafenib has proven one of the stars of the ASCO cancer conference by increasing overall survival in skin cancer …
News

GSK and Merck cut vaccine prices

June 6, 2011 Sales and Marketing Bill and Melinda Gates Foundation, GSK, Merck & Co, developing world, vaccines

GlaxoSmithKline and Merck & Co have pledged to offer their rotavirus vaccines at discounted prices to developing countries. GSK is …
News

UK pharma opposes off-label rule change

June 6, 2011 Sales and Marketing off label

Prescribing a drug off-label when a licenced alternative exists increases patient safety risks and threatens the development of new medicines, …
News

Novartis eye drug wins wider European licence

June 6, 2011 Sales and Marketing Lucentis, Novartis

Novartis’ Lucentis has been approved in Europe to treat people suffering from vision loss due to macular oedema secondary to …
News

BMS and Roche to team up in melanoma

June 3, 2011 Sales and Marketing BMS, Roche, melanoma, oncology

Bristol-Myers Squibb and Roche are to use two of their drugs in an exploratory phase I/II study a bid to …
News

UNICEF highlights price differences for vaccines

June 2, 2011 Sales and Marketing Unicef, developing world, vaccines

A large disparity in the cost of vaccines has been revealed by UNICEF. The United Nations Children’s Fund charity has …
News

AstraZeneca to stop paying for international conference trips

June 2, 2011 Medical Communications, Sales and Marketing AstraZeneca, congresses, ethics

AstraZeneca will no longer pay for doctors to attend international conferences. The move is the latest development in the industry’s …
News

Pfizer files new kidney cancer drug

June 2, 2011 Sales and Marketing Nexavar, Pfizer, rcc

Pfizer has filed its kidney cancer drug axitinib in the EU after impressive head-head- trials with Bayer’s Nexavar. Pfizer is …
News

Reforms will weaken health service accountability

June 1, 2011 Sales and Marketing NHS reform, king's fund

The government has received yet more unwelcome news on health policy with a leading think tank warning its reforms will …
News

J&J aims for Japanese pharma expansion

May 27, 2011 Research and Development, Sales and Marketing J&J, JJ

Johnson & Johnson has identified Japan as a key growth market for its pharma business as it outlines its strategic …
News

Pharma faces ‘trench warfare’ with NHS

May 26, 2011 Sales and Marketing Cost cutting, NHS, prescribing

The competing interests of the NHS and the pharma industry could end in trench warfare, a leading NHS figure has …
News

NICE to appraise hep C drugs Victrelis and telaprevir

May 26, 2011 Sales and Marketing Brinavess, Ilaris, NICE, Victrelis, Xarelto, Zytiga, telaprevir

NICE’s next round of drug appraisals is set to include two new hepatitis C drugs – Merck Sharpe and Dohme’s …
News

GSK’s Trobalt launched in UK

May 25, 2011 Sales and Marketing GlaxoSmithKline, Trobalt, epilepsy, retigabine

GSK has launched its new epilepsy treatment Trobalt in the UK. Trobalt (retigabine) is as adjunctive treatment of partial onset …
News

NICE U-turn on Roche’s MabThera

May 25, 2011 Sales and Marketing MabThera, NICE, Roche

NICE has provisionally recommended Roche’s MabThera as a maintenance therapy for blood cancer patients. The new draft guidance backs MabThera’s …
News

J&J and Vertex’s hep C drug Incivek approved by FDA

May 24, 2011 Sales and Marketing FDA, Incivek, Johnson & Johnson, Vertex, hepatitis C, telaprevir

The FDA has approved Johnson & Johnson/Vertex’s new oral hepatitis C drug Incivek. Incivek (telaprevir), a protease inhibitor, is now …
News
The Gateway to Local Adoption Series

Latest content

Scots neonatal innovations target hearing loss and earlier care

August 28, 2026

FDA grants De Novo authorisation to light-filtering device for migraine

August 28, 2026

Southgate opens Innovation Lab for logistics and fulfilment development

August 27, 2026

Bioptimus partners with Cancer Research Horizons to expand AI cancer data set

August 27, 2026

Agentis Health Group acquires Clinical Pharmacist Solutions

August 26, 2026